| Primary |
| Depression |
45.5% |
| Anxiety |
9.1% |
| Product Used For Unknown Indication |
9.1% |
| Arthralgia |
4.5% |
| Asthma |
4.5% |
| Dysthymic Disorder |
4.5% |
| Fibromyalgia |
4.5% |
| Gastritis |
4.5% |
| Insomnia |
4.5% |
| Panic Disorder |
4.5% |
| Seasonal Affective Disorder |
4.5% |
|
| Fall |
9.5% |
| Systemic Lupus Erythematosus |
9.5% |
| Ventricular Extrasystoles |
9.5% |
| Acute Hepatic Failure |
4.8% |
| Anxiety |
4.8% |
| Blood Sodium Decreased |
4.8% |
| Cognitive Disorder |
4.8% |
| Drug Level Decreased |
4.8% |
| Dyskinesia |
4.8% |
| Hepatic Enzyme Increased |
4.8% |
| Medication Error |
4.8% |
| Muscle Twitching |
4.8% |
| Swollen Tongue |
4.8% |
| Tachycardia |
4.8% |
| Therapeutic Response Unexpected With Drug Substitution |
4.8% |
| Tremor |
4.8% |
| Visual Impairment |
4.8% |
| Weight Increased |
4.8% |
|
| Secondary |
| Depression |
29.4% |
| Migraine |
14.7% |
| Drug Use For Unknown Indication |
8.8% |
| Gastritis |
8.8% |
| Blood Cholesterol Increased |
5.9% |
| Intentional Overdose |
5.9% |
| Anxiety |
2.9% |
| Bipolar I Disorder |
2.9% |
| Hiv Infection |
2.9% |
| Hypercholesterolaemia |
2.9% |
| Hyperlipidaemia |
2.9% |
| Insomnia |
2.9% |
| Major Depression |
2.9% |
| Panic Disorder |
2.9% |
| Seasonal Affective Disorder |
2.9% |
|
| Dyskinesia |
14.3% |
| Rhabdomyolysis |
14.3% |
| Tachycardia |
9.5% |
| Constipation |
4.8% |
| Dizziness |
4.8% |
| Drug Intolerance |
4.8% |
| Haemoglobin Increased |
4.8% |
| Medication Error |
4.8% |
| Mental Disorder |
4.8% |
| Serotonin Syndrome |
4.8% |
| Sinus Tachycardia |
4.8% |
| Social Avoidant Behaviour |
4.8% |
| Somnolence |
4.8% |
| Tearfulness |
4.8% |
| Visual Impairment |
4.8% |
| Weight Increased |
4.8% |
|
| Concomitant |
| Drug Use For Unknown Indication |
18.0% |
| Depression |
13.9% |
| Product Used For Unknown Indication |
12.7% |
| Hypertension |
6.8% |
| Anxiety |
6.6% |
| Pain |
4.6% |
| Insomnia |
3.9% |
| Back Pain |
3.7% |
| Psoriatic Arthropathy |
3.4% |
| Epilepsy |
3.2% |
| Bipolar Disorder |
2.9% |
| Sleep Disorder |
2.9% |
| Nausea |
2.7% |
| Sleep Apnoea Syndrome |
2.4% |
| Vitamin Supplementation |
2.4% |
| Squamous Cell Carcinoma |
2.2% |
| Blood Cholesterol Increased |
2.0% |
| Colon Cancer |
2.0% |
| Menopausal Symptoms |
2.0% |
| Diabetes Mellitus |
1.7% |
|
| Weight Increased |
13.5% |
| Type 2 Diabetes Mellitus |
9.0% |
| Vomiting |
6.7% |
| Injection Site Pain |
5.6% |
| Pain |
5.6% |
| Tardive Dyskinesia |
5.6% |
| Tremor |
5.6% |
| Nausea |
4.5% |
| Pancreatitis |
4.5% |
| Sudden Unexplained Death In Epilepsy |
4.5% |
| Withdrawal Syndrome |
4.5% |
| Drug Ineffective |
3.4% |
| Flushing |
3.4% |
| Obesity |
3.4% |
| Product Quality Issue |
3.4% |
| Suicide Attempt |
3.4% |
| Tachycardia |
3.4% |
| Thinking Abnormal |
3.4% |
| Urticaria |
3.4% |
| Vision Blurred |
3.4% |
|
| Interacting |
| Depression |
40.0% |
| Product Used For Unknown Indication |
40.0% |
| Smoking Cessation Therapy |
20.0% |
|
| Drug Level Decreased |
20.0% |
| Mental Impairment |
20.0% |
| Secondary Adrenocortical Insufficiency |
20.0% |
| Tachycardia |
20.0% |
| Weight Increased |
20.0% |
|
